Aspire Biopharma faces potential Nasdaq delisting after compliance shortfall
LONDON - Worldwide Healthcare Trust PLC (LON:WWH) announced Wednesday that shareholders approved the renewal of the company’s share buyback authority at a General Meeting held the same day.
The special resolution, which authorizes the company to make market purchases of its ordinary shares, passed with 96.96% approval. According to the company’s statement, 182,494,356 votes were cast in favor of the resolution, while 5,718,960 votes were against.
The meeting had a 46.19% turnout of the company’s issued share capital with voting rights. A total of 133,156 votes were withheld, which do not count toward the final tally.
As of the meeting date, Worldwide Healthcare Trust had 407,515,824 ordinary shares in issue, with 194,149,376 shares held in treasury. The total number of voting rights was 407,515,824.
The full text of the resolution was included in the Notice of the General Meeting sent to shareholders on September 12, 2025, according to the press release statement.
Worldwide Healthcare Trust PLC is identified by the Legal Entity Identifier 5493003YBCY4W1IMJU04.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.